Steward Partners Investment Advisory’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-331
Closed -$22.3K 3632
2023
Q4
$22.3K Buy
331
+89
+37% +$6.2K ﹤0.01% 2350
2023
Q3
$18.1K Buy
242
+58
+32% +$5.15K ﹤0.01% 2358
2023
Q2
$17K Sell
184
-107
-37% -$9.53K ﹤0.01% 2366
2023
Q1
$30.2K Sell
291
-1,385
-83% -$153K ﹤0.01% 2078
2022
Q4
$193K Sell
1,676
-186
-10% -$21.7K ﹤0.01% 1253
2022
Q3
$202K Sell
1,862
-54
-3% -$7.74K ﹤0.01% 1198
2022
Q2
$346K Sell
1,916
-19
-1% -$3.4K 0.01% 978
2022
Q1
$330K Buy
1,935
+557
+40% +$105K 0.01% 1086
2021
Q4
$289K Buy
1,378
+177
+15% +$36.6K ﹤0.01% 1155
2021
Q3
$231K Buy
1,201
+146
+14% +$35.9K ﹤0.01% 1216
2021
Q2
$299K Buy
+1,055
New +$286K 0.01% 1190
2019
Q3
Sell
-35
Closed -$4K 2702
2019
Q2
$4K Buy
+35
New +$4.86K ﹤0.01% 2285
2018
Q4
Sell
-70
Closed -$16K 1577
2018
Q3
$16K Hold
70
﹤0.01% 1657
2018
Q2
$11K Buy
70
+1
+1% +$128 ﹤0.01% 1701
2018
Q1
$6K Hold
69
﹤0.01% 1732
2017
Q4
$4K Buy
69
+1
+1% +$66 ﹤0.01% 1567
2017
Q3
$4K Hold
68
﹤0.01% 1357
2017
Q2
$2K Hold
68
﹤0.01% 1430
2017
Q1
$3K Buy
+68
New +$2.93K ﹤0.01% 1244

Other funds holding MED

Steward Partners Investment Advisory's MED Position: Q1 2024 in Review

Steward Partners Investment Advisory sold out of Medifast (MED) in Q1 2024, closing a stake of 331 shares — an estimated $22.3K sold.

Steward Partners Investment Advisory first reported a position in MED in Q1 2017 and held it in 19 quarters. The position peaked at $346K in Q2 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Steward Partners Investment Advisory reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 331 Medifast shares in Q1 2024, an estimated $22.3K.
  • Steward Partners Investment Advisory first reported a position in Medifast in Q1 2017 and held it in 19 quarters.
  • Steward Partners Investment Advisory's Medifast position peaked at $346K in Q2 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.